Stock Taper
IMRX
IMMUNEERING CORPORATION
NASDAQ
$4.99
▼ DOWN 4.22% (-0.22)

KEY STATISTICS

Market Cap$181.15 M
52w High$10.08
52w Low$3.86
Dividend Yield
Frequency
P/E-4.80
Volume793.04K
Shares Out.36.30M

COMPANY

LEADERSHIP

Benjamin J. Zeskind
CHIEF EXECUTIVE
Benjamin J. Zeskind

COMPENSATION 2026

Salary$641,493
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$16,230
Total$1,660,612

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 30, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
57

PRICE TARGET

Target High$17.00
Target Low$12.00
Target Median$14.00
Target Consensus$14.33

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.
NOV
11
WED

PRICE

$4.99 ▼ DOWN 4.22% (−$0.22)
$5.00$5.10$5.209:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM4.99

About Immuneering Corporation

https://immuneering.com ↗

Immuneering Corporation, based in Cambridge, MA, develops oncology and neuroscience therapies, including dual-MEK inhibitors like IMM-1-104 for cancers with RAS/RAF mutations, with additional discovery-stage programs targeting MAPK and mTOR pathways.

INDUSTRY

Biotechnology

A PRODUCT IMMUNEERING CORPORATION IS KNOWN FOR

Atebimetinib (IMM-1-104)
Atebimetinib (IMM-1-104)

Atebimetinib is an oral MEK inhibitor and Immuneering's lead candidate in Phase 3 for pancreatic cancer, aiming to improve durability and tolerability in treating MAPK pathway-driven tumors.

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

OFFICER: CHIEF FINANCIAL OFFICER
Gengos Andrew
Purchase · 650.0K shares
2026-07-16
OFFICER: CHIEF FINANCIAL OFFICER
Gengos Andrew
· —
2026-07-16
DIRECTOR, OFFICER: PRESIDENT AND CEO
Zeskind Benjamin J.
Purchase · 2.4K shares
2026-06-23
OFFICER: CHIEF SCIENTIFIC OFFICER
Hall Brett Matthew
Purchase · 6.0K shares
2026-06-15

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
OUTPERFORM 1
4 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
ASMB$34.07COMPARE
ZURA$5.72COMPARE
ARCT$15.19COMPARE
ENTA$13.60COMPARE
FHTX$6.00COMPARE
TRDA$7.00COMPARE
PYXS$3.23COMPARE
TNYA$0.69COMPARE